5-tert-butyl-3-fluoro-2-methylpyrazolo[1,5-a]pyridine;3-tert-butylimidazo[1,2-a]pyrazine;5-tert-butylpyrazolo[1,5-a]pyrimidine;6-tert-butyl-[1,2,4]triazolo[4,3-a]pyridine;2,2-difluoro-5-propan-2-yl-1,3-benzodioxole;bis(2,2-dimethylpropane);methane;2-methyl-1,3-benzoxazole;2-methyl-3H-indole;6-propan-2-yl-3,4-dihydro-2H-chromene;6-propan-2-ylimidazo[1,2-a]pyrazine
C104H147F3N16O4 — CID 158144951
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-tert-butyl-3-fluoro-2-methylpyrazolo[1,5-a]pyridine;3-tert-butylimidazo[1,2-a]pyrazine;5-tert-butylpyrazolo[1,5-a]pyrimidine;6-tert-butyl-[1,2,4]triazolo[4,3-a]pyridine;2,2-difluoro-5-propan-2-yl-1,3-benzodioxole;bis(2,2-dimethylpropane);methane;2-methyl-1,3-benzoxazole;2-methyl-3H-indole;6-propan-2-yl-3,4-dihydro-2H-chromene;6-propan-2-ylimidazo[1,2-a]pyrazine
5-tert-butyl-3-fluoro-2-methylpyrazolo[1,5-a]pyridine;3-tert-butylimidazo[1,2-a]pyrazine;5-tert-butylpyrazolo[1,5-a]pyrimidine;6-tert-butyl-[1,2,4]triazolo[4,3-a]pyridine;2,2-difluoro-5-propan-2-yl-1,3-benzodioxole;bis(2,2-dimethylpropane);methane;2-methyl-1,3-benzoxazole;2-methyl-3H-indole;6-propan-2-yl-3,4-dihydro-2H-chromene;6-propan-2-ylimidazo[1,2-a]pyrazine (PubChem CID 158144951) has the molecular formula C104H147F3N16O4 and a molecular weight of 1742.42 g/mol. Its IUPAC name is 5-tert-butyl-3-fluoro-2-methylpyrazolo[1,5-a]pyridine;3-tert-butylimidazo[1,2-a]pyrazine;5-tert-butylpyrazolo[1,5-a]pyrimidine;6-tert-butyl-[1,2,4]triazolo[4,3-a]pyridine;2,2-difluoro-5-propan-2-yl-1,3-benzodioxole;bis(2,2-dimethylpropane);methane;2-methyl-1,3-benzoxazole;2-methyl-3H-indole;6-propan-2-yl-3,4-dihydro-2H-chromene;6-propan-2-ylimidazo[1,2-a]pyrazine.
Molecular Properties
| Compound Name | 5-tert-butyl-3-fluoro-2-methylpyrazolo[1,5-a]pyridine;3-tert-butylimidazo[1,2-a]pyrazine;5-tert-butylpyrazolo[1,5-a]pyrimidine;6-tert-butyl-[1,2,4]triazolo[4,3-a]pyridine;2,2-difluoro-5-propan-2-yl-1,3-benzodioxole;bis(2,2-dimethylpropane);methane;2-methyl-1,3-benzoxazole;2-methyl-3H-indole;6-propan-2-yl-3,4-dihydro-2H-chromene;6-propan-2-ylimidazo[1,2-a]pyrazine |
|---|---|
| PubChem CID | 158144951 |
| Molecular Formula | C104H147F3N16O4 |
| Molecular Weight | 1742.42 g/mol |
| Exact Mass | 1741.17 |
| IUPAC Name | 5-tert-butyl-3-fluoro-2-methylpyrazolo[1,5-a]pyridine;3-tert-butylimidazo[1,2-a]pyrazine;5-tert-butylpyrazolo[1,5-a]pyrimidine;6-tert-butyl-[1,2,4]triazolo[4,3-a]pyridine;2,2-difluoro-5-propan-2-yl-1,3-benzodioxole;bis(2,2-dimethylpropane);methane;2-methyl-1,3-benzoxazole;2-methyl-3H-indole;6-propan-2-yl-3,4-dihydro-2H-chromene;6-propan-2-ylimidazo[1,2-a]pyrazine |
| SMILES | C.C.C.C.CC(C)(C)C.CC(C)(C)C.CC(C)(C)c1ccc2nncn2c1.CC(C)(C)c1ccn2nccc2n1.CC(C)(C)c1cnc2cnccn12.CC(C)c1ccc2c(c1)CCCO2.CC(C)c1ccc2c(c1)OC(F)(F)O2.CC(C)c1cn2ccnc2cn1.CC1=Nc2ccccc2C1.Cc1nc2ccccc2o1.Cc1nn2ccc(C(C)(C)C)cc2c1F |
| InChI | InChI=1S/C12H15FN2.C12H16O.C10H10F2O2.3C10H13N3.C9H11N3.C9H9N.C8H7NO.2C5H12.4CH4/c1-8-11(13)10-7-9(12(2,3)4)5-6-15(10)14-8;1-9(2)10-5-6-12-11(8-10)4-3-7-13-12;1-6(2)7-3-4-8-9(5-7)14-10(11,12)13-8;1-10(2,3)8-5-7-13-9(12-8)4-6-11-13;1-10(2,3)8-6-12-9-7-11-4-5-13(8)9;1-10(2,3)8-4-5-9-12-11-7-13(9)6-8;1-7(2)8-6-12-4-3-10-9(12)5-11-8;1-7-6-8-4-2-3-5-9(8)10-7;1-6-9-7-4-2-3-5-8(7)10-6;2*1-5(2,3)4;;;;/h5-7H,1-4H3;5-6,8-9H,3-4,7H2,1-2H3;3-6H,1-2H3;3*4-7H,1-3H3;3-7H,1-2H3;2-5H,6H2,1H3;2-5H,1H3;2*1-4H3;4*1H4 |
| InChIKey | FUKCECHGQYQETF-UHFFFAOYSA-N |
| XLogP | 28.40 |
| TPSA | 204.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 127 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1742.42 |
| LogP ≤ 5 | 28.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158144951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.